Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
national blog main
san diego blog main
san diego top stories
3
×
clinical trials
fda
san diego
abide therapeutics
achaogen
adams street partners
allergan
amylin pharmaceuticals
antibiotics
ben cravatt
beta lactamase inhibitor
biomedical advanced research and development authority (barda)
biotech ipos
boston
boston blog main
boston top stories
botox
bristol-myers squibb
deals
drug resistance
drugs
dyne therapeutics
epilepsy
executives
gabapentin
hatteras venture partners
hiring
investing
kevin finney
life science
lyzz capital
macrolide pharmaceuticals
melinta therapeutics
meropenem
metacrine
What
medicines
3
×
therapeutics
3
×
company
developing
drug
abide
appointed
bacteria
biopharma
brings
business
chief
disease
diseases
disorders
dyne
dyne’s
executive
exited
fighting
finney
genetic
infections
infectious
ipo
kevin
launches
melinta
million
muscle
muscular
neurological
officer
operating
preclinical
president
products
qpex
raised
rare
Language
unset
Current search:
therapeutics
×
medicines
×
" san diego top stories "
×
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
5 years ago
Former Zavante Executive Tapped as Abide Therapeutics President
@xconomy.com
5 years ago
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections